A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies

NCT00761696 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
94
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Infinity Pharmaceuticals, Inc.